Fig. 2.
Distribution of α/β+ and γ/δ+ T cells and coexpression of BLR1 on these subpopulations on PBL derived from healthy (○; n = 15) or HIV-infected subjects (•; n = 69). PBL were stained with anti-BLR1-biotin/strepavidin-cychrome and were either incubated with anti-α/β+ TCR-FITC MoAb or with anti-γ/δ+ TCR-FITC MoAb. The percentage of T cells expressing α/β or γ/δ chains was calculated (A) and the percentage of BLR1+ cells in each subpopulation was determined (B). Results are the mean ± SD. ***P < .001 versus HIV− control.